GE HealthCare Technologies Inc. (NASDAQ:GEHC) — Market Cap & Net Worth
Market Cap & Net Worth: GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (NASDAQ:GEHC) has a market capitalization of $28.94 Billion ($28.94 Billion) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #924 globally and #403 in its home market, demonstrating a -6.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GE HealthCare Technologies Inc.'s stock price $64.07 by its total outstanding shares 451686252 (451.69 Million). Also see how large is GE HealthCare Technologies Inc.'s balance sheet for a full breakdown of the balance sheet.
GE HealthCare Technologies Inc. Market Cap History: 2022 to 2026
GE HealthCare Technologies Inc.'s market capitalization history from 2022 to 2026. Data shows growth from $26.30 Billion to $28.94 Billion (1.84% CAGR). Also see GE HealthCare Technologies Inc. operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
GE HealthCare Technologies Inc. is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$62.85 Trillion | 0.06% | #289 of 503 |
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 1.09% | #15 of 976 |
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.07% | #120 of 3165 |
|
Nasdaq 100
NDX
|
$35.08 Trillion | 0.08% | #89 of 101 |
Weight: GE HealthCare Technologies Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GE HealthCare Technologies Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GE HealthCare Technologies Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check GE HealthCare Technologies Inc. stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.80x
GE HealthCare Technologies Inc.'s market cap is 1.80 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.78x
GE HealthCare Technologies Inc.'s market cap is 17.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $26.30 Billion | $18.34 Billion | $1.92 Billion | 1.43x | 13.73x |
| 2023 | $34.87 Billion | $19.55 Billion | $3.10 Billion | 1.78x | 11.24x |
| 2024 | $35.50 Billion | $19.67 Billion | $1.99 Billion | 1.80x | 17.81x |
| 2025 | $37.05 Billion | $20.62 Billion | $2.08 Billion | 1.80x | 17.78x |
Competitor Companies of GEHC by Market Capitalization
Companies near GE HealthCare Technologies Inc. in the global market cap rankings as of September 17, 2026. Review GEHC tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to GE HealthCare Technologies Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
GE HealthCare Technologies Inc. Historical Marketcap From 2022 to 2026
Between 2022 and today, GE HealthCare Technologies Inc.'s market cap moved from $26.30 Billion to $ 28.94 Billion, with a yearly change of 1.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $28.94 Billion | -21.88% |
| 2025 | $37.05 Billion | +4.35% |
| 2024 | $35.50 Billion | +1.80% |
| 2023 | $34.87 Billion | +32.60% |
| 2022 | $26.30 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of GE HealthCare Technologies Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.94 Billion USD |
| MoneyControl | $28.94 Billion USD |
| MarketWatch | $28.94 Billion USD |
| marketcap.company | $28.94 Billion USD |
| Reuters | $28.94 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical… Read more